3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
alvimopan
5
Surveys and Questionnaires
2
Cyclophosphamide
2
pralsetinib
1
pembrolizumab
1
napabucasin
1
guadecitabine
1
Ursodeoxycholic Acid
1
Surgical Procedures, Operative
1
Pemetrexed
1
Oxaliplatin
1
Oviposition
1
Ocoxin
1
Low Density Lipoprotein Receptor-Related Protein-1
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Exercise
1
Drainage
1
Colonoscopy
1
Cetuximab
1
Celecoxib
1
Capecitabine
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Intestinal Diseases
×
Oviposition
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled